CRM — Salesforce, Inc.

The Q2 FY27 print flipped sentiment from deep skepticism to renewed optimism. Revenue grew 10.8% YoY to $11.35B, non-GAAP EPS of $5.90 beat consensus, Agentforce hit $1B in ARR, and management raised full-year EPS guidance to $16.67-$16.71. Multiple analysts lifted price targets following the report, but the one-day 22.6% move means much of the good news is already in the price.

Revenue growth has inflected upward: YoY growth bottomed in the 7-8% range in late FY2025, then reaccelerated to 9.8%, 8.6%, 12.1%, 13.3%, and 10.8% over the last five reported quarters. Operating margin is more mixed—Q2 FY27 operating margin fell to roughly 20.5% from 22.8% a year earlier as Salesforce invests in AI and integrates acquisitions, after a period of earlier expansion. GAAP net income in Q2 FY27 was flattered by a large non-cash mark-to-market gain on its Anthropic stake, so the $3.53B net income figure overstates operational earnings. Free cash flow jumped 81% YoY to $1.1B in the quarter. Net read: the topline inflection is real, but earnings quality is temporarily muddied by one-off gains and investment spending.

As of 2026-08-27, the headline P/E of 22.9x TTM earnings looks reasonable but flatters the stock because TTM EPS includes non-operating investment gains. On FY27 non-GAAP EPS guidance midpoint of $16.69, the forward P/E is about 15.1x. The PEG is 0.40 and price-to-sales is 4.7x versus the 5-year average of 7.0x. So on a historical basis the stock is cheap, but on forward earnings it is merely fairly priced for a ~10% grower with margin pressure and balance-sheet leverage.

After the surge from $146 to $252, the stock is pricing in the Agentforce inflection and a raised guidance trajectory, but not hypergrowth. At roughly 15x forward non-GAAP EPS, the market is paying for steady sequential improvement. If subscription re-acceleration to ~8.4% constant-currency growth by Q4 materializes, earnings upgrades can drive further upside. If that sequential acceleration disappoints, the stock has a large air pocket below it given the single-day spike.

As of 2026-08-27, RSI(14) is 79.97, which is overbought. Price is 26.0% above the 20-day SMA, 40.9% above the 50-day SMA, and 25.9% above the 200-day SMA. The trend is strongly bullish after the earnings breakout, but the stock is extended and the entry timing is poor without a pullback or consolidation period.

• Lingering high long-term Treasury yields raise the discount rate for long-duration software cash flows, though expected easing provides a potential tailwind.
• Enterprise IT budgets remain skewed toward AI infrastructure, forcing software vendors to prove immediate ROI; Salesforce has partially decoupled via Agentforce monetization.
• AI agent substitution fears persist—customers could buy fewer traditional per-seat licenses as autonomous agents handle more work.
• Geopolitical and trade frictions keep enterprise buyers disciplined, extending sales cycles and pressuring near-term spending.
• The broader AI/software valuation cycle is stretched, so sentiment can reverse quickly if macro or AI demand data weakens.

• Dreamforce: expected Agentforce v4 launch, deeper ITSM expansion, and tighter Anthropic/Claude integrations.
• Subscription re-acceleration: management guides constant-currency subscription growth to step up from 6% in Q2 to ~7.1% in Q3 and ~8.4% in Q4.
• U.S. Army $5.6B contract execution milestones beginning to contribute material revenue.
• Further mark-to-market gains on the Anthropic stake could add non-operating income, though these are not core earnings.

• AI agents cannibalize traditional seat-based CRM pricing, pressuring net revenue retention and renewal economics.
• Operating margin compression from Agentforce investments, acquisitions, and AI infrastructure costs.
• Earnings quality: Q2 GAAP net income includes a large non-cash investment gain, so normalized P/E is higher than the headline 22.9x.
• Balance sheet is more levered than typical software peers: $39.3B long-term debt, $8.3B cash, and a 0.84 current ratio.
• Overbought technicals after a 22.6% one-day move make the stock vulnerable to a sharp pullback.

Salesforce is a high-quality franchise showing a genuine AI-driven reacceleration, and the stock is much more attractive than it was at $146. But after a 22.6% one-day jump to $252, the easy money has been made near-term. I would not chase here; the better risk/reward is to wait for a pullback toward the 20-day or 50-day moving average, while treating any Agentforce execution miss as a red flag.

Applying an 18x forward multiple to FY27 non-GAAP EPS guidance midpoint of $16.69 yields $300.42. That multiple is below the company's 5-year average P/S of 7.0x and reflects ~10% revenue growth, 77% gross margin, and improving FCF, while still accounting for margin investment, balance-sheet leverage, and AI transition risk.